Alpine Immune Sciences Price History

ALPNDelisted Stock  USD 12.37  0.23  1.83%   
If you're considering investing in Alpine Stock, it is important to understand the factors that can impact its price. As of today, the current price of Alpine Immune stands at 12.37, as last reported on the 3rd of December, with the highest price reaching 12.64 and the lowest price hitting 12.14 during the day. We have found thirty technical indicators for Alpine Immune Sciences, which you can use to evaluate the volatility of the firm. Please confirm Alpine Immune's Risk Adjusted Performance of 0.1869, mean deviation of 2.72, and Downside Deviation of 2.36 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Alpine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ALPN
Based on monthly moving average Alpine Immune is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alpine Immune by adding Alpine Immune to a well-diversified portfolio.

Alpine Immune Stock Price History Chart

There are several ways to analyze Alpine Stock price data. The simplest method is using a basic Alpine candlestick price chart, which shows Alpine Immune price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Alpine Stock Price History Data

The price series of Alpine Immune for the period between Wed, Sep 4, 2024 and Tue, Dec 3, 2024 has a statistical range of 5.71 with a coefficient of variation of 17.01. The prices are distributed with arithmetic mean of 9.73. The median price for the last 90 days is 10.3. The company had 1:4 stock split on 25th of July 2017. Alpine Immune Sciences issued dividends on 2017-07-25.
OpenHighLowCloseVolume
12/03/2024
 12.60  12.64  12.14  12.37 
07/24/2023 12.60  12.64  12.14  12.37  110,007 
07/21/2023 12.03  12.78  11.91  12.55  214,100 
07/20/2023 11.62  12.08  11.62  11.84  133,862 
07/19/2023 11.40  11.82  11.40  11.63  62,863 
07/18/2023 11.25  11.50  11.23  11.42  151,116 
07/17/2023 11.10  11.38  11.06  11.36  152,305 
07/14/2023 10.82  11.06  10.76  11.03  85,817 
07/13/2023 10.49  10.88  10.38  10.83  299,062 
07/12/2023 10.94  10.94  10.38  10.42  110,091 
07/11/2023 10.71  10.99  10.60  10.77  65,396 
07/10/2023 10.04  10.85  10.04  10.72  66,863 
07/07/2023 10.31  10.31  9.94  10.13  77,320 
07/06/2023 10.63  10.63  10.11  10.29  113,186 
07/05/2023 10.10  10.78  10.08  10.64  93,050 
07/03/2023 10.27  10.29  10.01  10.14  51,876 
06/30/2023 10.35  10.48  10.03  10.28  177,373 
06/29/2023 10.41  10.41  10.01  10.30  114,893 
06/28/2023 10.53  10.53  10.15  10.42  197,772 
06/27/2023 10.95  11.10  10.43  10.49  184,721 
06/26/2023 11.27  11.27  10.73  10.94  1,164,416 
06/23/2023 11.43  11.70  10.72  11.16  1,097,089 
06/22/2023 11.71  12.04  11.56  11.63  76,817 
06/21/2023 11.99  11.99  11.41  11.85  183,307 
06/20/2023 11.28  11.97  10.97  11.91  391,284 
06/16/2023 11.04  11.38  10.97  11.28  355,696 
06/15/2023 11.08  11.29  10.61  10.90  151,669 
06/14/2023 11.21  11.45  11.02  11.10  122,162 
06/13/2023 11.37  11.58  10.90  11.12  199,169 
06/12/2023 10.50  11.62  10.48  11.26  444,688 
06/09/2023 10.40  10.59  10.19  10.27  64,241 
06/08/2023 10.63  10.67  10.19  10.37  63,150 
06/07/2023 10.83  11.12  10.48  10.57  119,514 
06/06/2023 10.61  11.02  10.07  10.80  105,189 
06/05/2023 10.39  10.97  10.39  10.72  96,806 
06/02/2023 10.31  10.56  10.03  10.53  89,926 
06/01/2023 9.90  10.36  9.57  10.24  160,121 
05/31/2023 9.95  10.58  9.80  9.96  100,989 
05/30/2023 9.87  10.01  9.38  9.95  158,272 
05/26/2023 10.08  10.21  9.84  9.90  74,806 
05/25/2023 10.54  10.54  9.81  10.05  100,860 
05/24/2023 10.52  10.74  10.47  10.54  99,758 
05/23/2023 10.61  10.95  10.44  10.51  176,888 
05/22/2023 9.50  10.65  9.40  10.51  364,973 
05/19/2023 8.75  9.53  8.59  9.50  1,207,078 
05/18/2023 8.50  8.66  8.40  8.60  251,268 
05/17/2023 8.61  8.69  8.54  8.58  74,921 
05/16/2023 8.52  8.71  8.52  8.57  180,565 
05/15/2023 8.29  8.78  8.14  8.67  397,156 
05/12/2023 7.86  8.24  7.78  8.17  104,309 
05/11/2023 7.71  7.95  7.71  7.78  99,702 
05/10/2023 7.57  7.95  7.55  7.87  150,547 
05/09/2023 7.48  7.48  7.32  7.37  14,756 
05/08/2023 7.41  7.57  7.25  7.48  22,316 
05/05/2023 6.93  7.44  6.93  7.39  43,803 
05/04/2023 6.96  6.96  6.71  6.84  42,192 
05/03/2023 7.12  7.44  6.96  6.99  81,189 
05/02/2023 7.48  7.48  7.01  7.08  39,289 
05/01/2023 7.45  7.60  7.25  7.49  69,767 
04/28/2023 7.23  7.66  7.10  7.49  32,071 
04/27/2023 7.20  7.50  7.14  7.24  21,018 

About Alpine Immune Stock history

Alpine Immune investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alpine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alpine Immune Sciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alpine Immune stock prices may prove useful in developing a viable investing in Alpine Immune
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmuneinflammatory disorders, and other diseases. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington. Alpine Immune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 85 people.

Alpine Immune Stock Technical Analysis

Alpine Immune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Alpine Immune technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Alpine Immune trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Alpine Immune Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Alpine Immune's price direction in advance. Along with the technical and fundamental analysis of Alpine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alpine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Consideration for investing in Alpine Stock

If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Transaction History
View history of all your transactions and understand their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio